Prostate Care Peptide
Natural health product licensed in Canada
- Other names
- Lie Kang Tai, Prostate Health Plus
- Licence holder
- SmartPEP (Canada) Biological Technology Research Ltd.
- NPN or DIN-HM
- 80064401
- Status
- Active licence
- Licence date
- 2 October 2015
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Serenoa repens (W.Bartram) Small: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Plantago asiatica Source : Plante entière Extraction ratio : 10:1 Dry plant equivalent : 500 mg | 50 mg | Not calculated |
| Salvia miltiorrhiza Source : Racine et rhizome Extraction ratio : 10:1 Dry plant equivalent : 556 mg | 55.6 mg | Not calculated |
| Lophatherum gracile Source : Feuille Extraction ratio : 10:1 Dry plant equivalent : 334 mg | 33.4 mg | Not calculated |
| Collagène hydrolysé Source : Poissons -Peau Extraction ratio : 2:1 Dry plant equivalent : 46 mg Potency : 0.7 mg L-lysine (3%) | 23 mg | Not calculated |
| Prunella vulgaris Source : Pointe de fruit Extraction ratio : 10:1 Dry plant equivalent : 500 mg | 50 mg | Not calculated |
| Crassostrea gigas Source : Shell Extraction ratio : 10:1 Dry plant equivalent : 500 mg | 50 mg | Not calculated |
| Paeonia anomala subsp. veitchii Source : Racine Extraction ratio : 10:1 Dry plant equivalent : 334 mg | 33.4 mg | Not calculated |
| Laminaria japonica Source : Thallus Extraction ratio : 10:1 Dry plant equivalent : 334 mg | 33.4 mg | Not calculated |
| Bupleurum chinense Source : Racine Extraction ratio : 10:1 Dry plant equivalent : 167 mg | 16.7 mg | Not calculated |
| Angelica sinensis Source : Racine Extraction ratio : 10:1 Dry plant equivalent : 334 mg | 33.4 mg | Not calculated |
| Fritillaria cirrhosa Source : Bulbe Extraction ratio : 10:1 Dry plant equivalent : 167 mg | 16.7 mg | Not calculated |
| Chrysanthemum x morifolium Source : Fleur Extraction ratio : 10:1 Dry plant equivalent : 278 mg | 27.8 mg | Not calculated |
| Saussurea costus Source : Racine Extraction ratio : 10:1 Dry plant equivalent : 167 mg | 16.7 mg | Not calculated |
| Piper longum Source : Fruit Extraction ratio : 10:1 Dry plant equivalent : 56 mg | 5.6 mg | Not calculated |
| Serenoa repens Source : Fruit Extraction ratio : 10:1 Dry plant equivalent : 56 mg | 5.6 mg | Not calculated |
Non-medicinal ingredients
Modified food starch, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 6 Capsule | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in Herbal Medicine to help relieve the urologic symptoms (e.g. weak urine flow, incomplete voiding, frequent daytime and night time urination) associated with mild to moderate benign prostatic hyperplasia
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80064401
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.